Forest Labs beats class certification bid in antidepressant marketing case - Reuters

Forest Labs beats class certification bid in antidepressant marketing caseReutersA federal judge on Tuesday denied class certification in a lawsuit claiming Allergan PLC's Forest Laboratories unit misled the public about the efficacy of its antidepressants Celexa and Lexapro in treating major depressive disorder in children. U.S ...